Experts say that if Trump follows through, the proposed tariffs could have far-reaching consequences for the cost and ...
Informing consumers and promoting innovative US manufacturing is a surer and safer path to reducing America’s reliance on imported drugs of uncertain quality ...
Health policy experts say higher import duties could increase costs and strain supplies while offering no guarantee manufacturers will shift production to the U.S.
The White House said the policy will be implemented under Section 232 authority, giving drugmakers two years to shift generic drug production to the U.S. before tariffs rise.
Zacks Investment Research on MSNOpinion

3 generic drug stocks to watch amid improving industry trends

Recent earnings across the generic drug industry point to a mixed but generally resilient operating environment. Reported ...
Trump's generic drug tariff plan raises questions over prices, U.S. manufacturing and which drugmakers stand to gain or lose as details remain unclear.
Trump plans to impose a 100% tariff on imported generic drugs in two years to bolster domestic manufacturing of these widely-used medications.
President Donald Trump on Tuesday announced a plan to impose a 100 percent tariff on generic drugs starting in August 2028 as part of a bid to push pharmaceutical production back to the United States.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...